ALSO NOTED: Critical Therapeutics closes private placement; Novartis extends cash offer; researchers tout copaxone study; and m

> Critical Therapeutics of Lexington, Mass. has closed on a private placement of $54.5 million. Release

> Novartis has extended its cash tender offer for all public shares of Eon Labs. Article

> Researchers are touting the positive results for copaxone in a four-year study. Release

And finally...Despite a massive ad campaign, most men with erectile dysfunction have never been treated for the condition. Story

Suggested Articles

Avidity Biosciences is on a roll—after inking an R&D deal with Eli Lilly and hiring a new CEO, the company is reeling in $100 million.

What the NASH field needs, says Genfit CEO Pascal Prigent, is something like the Hb1Ac test for diabetes.

Blocking a newly discovered molecule produced by B cells could slow their flow into the brain and offer a new way to treat MS, a Canadian team found.